Lv51
1230 积分 2022-06-07 加入
Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development
1小时前
已完结
Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes
3天前
已完结
Discovery of a Highly Potent and Efficient BRD9 Degrader with Strong In Vivo Antitumor Activity
3天前
已完结
The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects
6天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
7天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
2个月前
已完结
Biomacromolecule-mediated targeted protein degradation: an emerging strategy for cancer therapy
2个月前
已完结
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological Cancers
2个月前
已完结
SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT1
2个月前
已完结
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
2个月前
已完结
皖公网安备34019202002308
